Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bahtier M. Kurbanov"'
Publikováno v:
Experimental Dermatology. 17:1-11
In the last decades melanoma incidence has been increasing worldwide, while mortality remained on a high level. Until now, there is no suitable therapy for metastasized melanoma, which could lead to a significant increase in overall survival. Apoptos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58403c92897272a02a0bfd2779032ff0
https://doi.org/10.1111/j.1600-0625.2007.00655.x
https://doi.org/10.1111/j.1600-0625.2007.00655.x
Publikováno v:
Drug Resistance Updates. 10:218-234
The increased incidence of malignant melanoma in the last decades, its high mortality and pronounced therapy resistance pose an enormous challenge. Important therapeutic targets for melanoma are the induction of apoptosis and suppression of survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3538755cf5658a7425929531a4fe46ee
https://doi.org/10.1016/j.drup.2007.09.001
https://doi.org/10.1016/j.drup.2007.09.001
Publikováno v:
Oncogene. 26:3364-3377
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has attracted considerable attention as a novel anticancer agent. However, its efficiency may be diminished by occurring resistance in cancer cells. The mechanisms of TRAIL resistance in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1719ad47b4810b37eeaab42f0bd55f9
https://doi.org/10.1038/sj.onc.1210134
https://doi.org/10.1038/sj.onc.1210134
Autor:
Christoph C. Geilen, Lothar F. Fecker, Jürgen Eberle, Bahtier M. Kurbanov, Constantin E. Orfanos
Publikováno v:
Journal of Investigative Dermatology. 125:1010-1019
Therapy resistance is crucial for the high mortality of melanoma. The death ligand tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) bears high potential as a new anticancer agent, as binding to the death receptors TRAIL receptor 1/deat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fda04f5dd0d71988d1cab925980fe017
https://doi.org/10.1111/j.0022-202x.2005.23900.x
https://doi.org/10.1111/j.0022-202x.2005.23900.x
Autor:
Stefanie Rückert, Magdalena Schmude, Jürgen Eberle, Eggert Stockfleth, Henry Fechner, Bahtier M. Kurbanov, Lothar F. Fecker
Publikováno v:
Human gene therapy. 22(4)
High mortality and therapy resistance of melanoma demand the development of new strategies, and overcoming apoptosis deficiency appears as particularly promising. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown high potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61ad3ed8c0a12e42bbe8d23798dfea82
https://pubmed.ncbi.nlm.nih.gov/20977303
https://pubmed.ncbi.nlm.nih.gov/20977303
Publikováno v:
Experimental dermatology. 17(1)
In the last decades melanoma incidence has been increasing worldwide, while mortality remained on a high level. Until now, there is no suitable therapy for metastasized melanoma, which could lead to a significant increase in overall survival. Apoptos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::abb77a3e594ce8e7022fedbe4399d4fe
https://pubmed.ncbi.nlm.nih.gov/18095940
https://pubmed.ncbi.nlm.nih.gov/18095940
Autor:
Lothar F. Fecker, Stefanie Rückert, Bahtier M. Kurbanov, Magdalena Schmude, Eggert Stockfleth, Henry Fechner, Jürgen Eberle
Publikováno v:
Human Gene Therapy; Apr2011, Vol. 22 Issue 4, p405-417, 13p